Cholinesterase Inhibitors Dominance: Market Segmentation by Drug Class and Sustained Leadership in Symptomatic Management, 2025–2032
Market Overview Of Dementia and Alzheimer’s Disease Market The global Dementia and Alzheimer’s Disease Market is poised for exponential growth, fueled by the accelerating prevalence of the disease among the world’s aging population and, critically, the recent emergence of Disease-Modifying Therapies (DMTs) . These novel treatments, particularly those targeting amyloid beta pathology, are shifting the market landscape from purely symptomatic management to disease modification. According to market analysis, the market size, which was valued at USD 13.00 billion in 2022 , is projected to rocket up to USD 25.00 billion by 2030 . This significant expansion reflects a strong Compound Annual Growth Rate (CAGR) of 8.5% during the forecast period. The introduction of high-value, novel biologics, and the concurrent development of complementary diagnostics (especially blood-based biomarkers), are the primary forces be...